compounded tirzepatide/b6 Tirzepatide with Vitamin B6 1+GIP — tailored just to you. Compounded Tirzepatide with B6: Personalized

[4] [2] Clinical trials have demonstrated substantial reductions in hemoglobin A1c (up to 2.5%) and body weight (approximately 15-22.5% depending on dose in the SURMOUNT-1 trial), making it a significant advancement in metabolic disease treatment

Association for the Study of Obesity

This dual mechanism is significant because it mimics the effects of endogenous GIP while simultaneously promoting cAMP synthesis at the GLP-1 receptor, leading to a synergistic effect

Clinical trial data supporting safety and efficacy

Tirzepatide was not studied in patients with a history of pancreatitis or gastroparesis, so it is not known what its effect is on patients exhibiting these conditions